公司资料
Hoth Therapeutics 股价、新闻与催化剂
- 股票代码:
- HOTH
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
1.36 USD (+92.01%)
收盘价
最后更新: 2026年5月27日
26M USD
市值
股价为何变动
目前无法获取 HOTH 的收盘价变动背景。
公司概览
业务概览
Hoth Therapeutics is a biotechnology company focused on developing therapies across dermatology, inflammation, and oncology. Its story is built around a broad but still early-stage development portfolio.
所在地与行业分类
Hoth is headquartered in the United States and listed on NASDAQ. It sits in small-cap specialty biopharma.
商业模式特征
The company depends on preclinical and early clinical progress, capital efficiency, and the ability to prioritize programs. Investors usually watch proof-of-concept data and strategic changes.
生物医药行业定位
Hoth occupies a speculative small-cap biotech niche. Its stock tends to move on program updates because the company is still shaping its identity.
未来催化剂
- Hoth’s catalysts are its dermatology and inflammatory-disease programs, plus any strategic update that clarifies which assets still matter. The market will care about whether the company can keep a viable development path.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。